House of Lords Business
Show full summary

Lord Mendelsohn to ask Her Majesty's Government what assurances they have received that the research supported by UK Research and Innovation on vaccine responses in groups of immune-supressed individuals is adequate to support advice on responses for all blood cancers; and whether they have consulted Blood Cancer UK on this matter.  HL12369

Question HL12369: tabled on 20 January 2021 and due for answer by 3 February 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask Her Majesty's Government what assurances they have received that the research supported by UK Research and Innovation on vaccine responses in groups of immune-supressed individuals is adequate to support advice on responses for all blood cancers; and whether they have consulted Blood Cancer UK on this matter.  HL12369
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer